Search Results

Tris Pharma, Inc. has entered into a licensing agreement with Braingaze Ltd. and launched its new business, Tris Digital Health, which will focus on the development and commercialization of digital diagnostic and therapeutic products for neurological health conditions.

The Sickle Cell Disease Foundation (SCDF) is proud to announce a research collaboration agreement (RCA) with the U.S. Food and Drug Administration’s (FDA) Center for Devices and Radiological Health (CDRH) to develop best practices for the safe and effective use of artificial intelligence (AI) and machine learning (ML) systems and digitally-derived measures that matter to patients.

Aptar Digital Health today announced a partnership to help support patients with chronic diseases to manage their psychological stress and emotional wellbeing.

Indivi, a leading MedTech company headquartered in Basel, Switzerland, has entered into an agreement with Biogen to advance digital health technology and develop digital biomarkers for Parkinson’s disease.

iCAD, Inc. (NASDAQ: ICAD) a global leader on a mission to create a world where cancer can’t hide by providing clinically proven AI-powered breast health solutions, announced today the Company will present at the MedInvest MedTech, AI & Digital Healthcare Conference on June 11-12, 2024 in San Francisco, CA.

Leal Health (“Leal’’ or “the Company’’), a patient-first, AI-powered treatment platform revolutionizing patient access to cancer care, announced today that it will unveil new data on the benefits of digital health and AI-powered platforms for bridging cancer care gaps among diverse patient populations at this year’s American Society of Clinical Oncology (ASCO) Annual Meeting.